{"id":298,"date":"2021-02-28T10:58:07","date_gmt":"2021-02-28T01:58:07","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/?page_id=298"},"modified":"2022-11-10T10:01:59","modified_gmt":"2022-11-10T01:01:59","slug":"2021-2","status":"publish","type":"page","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/works\/2021-2\/","title":{"rendered":"2021"},"content":{"rendered":"

\u539f\u8457\u8ad6\u6587<\/strong><\/span><\/p>\n

    \n
  1. Yamashita A, Nishihira K, Gi T, Maekawa K, Hatakeyama K, Horiuchi S, Wada K, Shibata Y, Asada Y. Pathological features of ruptured coronary plaque and thrombus interfaces: Fibrin and von Willebrand factor as platelet scaffolds on rupture sites.<\/a> Thromb Haemost. 2021;121:234-241. doi: 10.1055\/s-0040-1716539.<\/span><\/li>\n
  2. Yamashita S, Masuda D, Akishita M, Arai H, Asada Y, Dobashi K, Egashira K, Harada-Shiba M, Hirata K, Ishibashi S, Kajinami K, Kinoshita M, Kozaki K, Kuzuya M, Ogura M, Okamura T, Sato K, Shimano H, Tsukamoto K, Yokode M, Yokote K, Yoshida M. Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia.<\/a> J Atheroscler Thromb. 2020 Aug 28. doi: 10.5551\/jat.CR004. Online ahead of print.<\/span><\/li>\n
  3. Nishimura M,\u00a0Yamashita A, Matsuura Y, Okutsu J, Fukahori A, Hirata T, Nishizawa T, Ishii H, Maekawa K, Nakamura E, Kitamura K, Nakamura K,\u00a0Asada Y. Upregulated kynurenine pathway enzymes in aortic atherosclerotic aneurysm: Macrophage kynureninase downregulates inflammation.\u00a0J Atheroscler Thromb. 2021;28:1214-1240.<\/span><\/span><\/li>\n
  4. Bao HL, Ishizuka T,\u00a0Yamashita A, Furukoji E,\u00a0Asada Y, Xu Y. Improving thermodynamic stability and anticoagulant activity of a thrombin binding aptamer by incorporation of 8-trifluoromethyl-2′-deoxyguanosine. J Med Chem.\u00a02021 Jan 14;64(1):711-718.<\/span><\/li>\n
  5. Gi T,\u00a0Yamashita A, Aman M, Kuwahara A,\u00a0Asada Y, Kawagoe Y, Onishi J, Sameshima H, Sato Y. Tissue factor expression and tumor-infiltrating T lymphocytes in ovarian carcinomas and their association with venous thromboembolism.\u00a0Pathol Int.\u00a0.2021;71:261-266.<\/span><\/span><\/li>\n
  6. Maekawa K, Tsuji AB, Yamashita A, Sugyo A, Katoh C, Tang M, Nishihira K, Shibata Y, Koshimoto C, Zhang MR, Nishii R, Yoshinaga K, Asada Y.\u00a0 Translocator protein imaging with 18F-FEDAC-positron emission tomography in rabbit atherosclerosis and its presence in human coronary vulnerable plaques. Atherosclerosis. 2021;337:7-17.<\/span><\/li>\n
  7. Koyama S, Yamashita A, Matsuura Y, Saito Y, Maekawa K, Gi T, Kitamura K, Asada Y. Intracellular glutamine level determines vascular smooth muscle cell-derived thrombogenicity. Atherosclerosis. 2021;328:62-73.<\/span><\/li>\n
  8. Sugita C, Yamashita A, Tsutsumi S, Kai H, Sonoda T, Yoshida H, Yamamoto R, Asada Y, Kurokawa M. Brazilian propolis (AF-08) inhibits collagen-induced platelet aggregation without affecting blood coagulation. J Nat Med. 2021;75:975-984.<\/span><\/li>\n
  9. Sawaguchi A, Kamimura T, Takahashi N, Yamashita A, Asada Y, Imazato H, Aoyama F, Wakui A, Sato T, Choijookhuu N, Hishikawa Y. In situ strategy for biomedical target localization via nanogold nucleation and secondary growth. Commun Biol. 2021;4:710.<\/span><\/li>\n
  10. Tsuruda T, Yoshikawa N, Kai M, Yamaguchi M, Toida R, Kodama T, Kajihara K, Kawabata T, Nakamura T, Sakata K, Hatakeyama K, Gi T,\u00a0Asada Y, Tono T, Kitamura K, Ikeda R. The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy. Intern Med. 2021;60:423-429.<\/span><\/li>\n
  11. Saito K, Yokogami K, Maekawa K,\u00a0et al.<\/em>High-resolution melting effectively pre-screens for\u00a0TP53<\/em>\u00a0mutations before direct sequencing in patients with diffuse glioma. Human Cell\u00a02021; 34:\u00a0<\/strong>644\u2013653.<\/span><\/li>\n
  12. Nanashima A, Tanoue Y, Imamura N, Hiyoshi M, Yano K, Hamada T, Nishida T, Kai K, Suzuki Y, Sato Y, Nakashima, Hosokawa A, Nagayasu T. Rare resected eight cases of duodenal adenocarcinomas. International Journal of Surgery Case Reports 2021, 86: 106384.<\/span><\/li>\n
  13. \u767d\u6ff1\u3000\u5e78\u751f, \u4f50\u85e4\u3000\u52c7\u4e00\u90ce, \u6e05\u5c71\u3000\u548c\u662d, \u91ce\u53e3\u3000\u88d5\u53f2, \u6797\u3000\u900f, \u80a5\u5f8c\u3000\u8cb4\u53f2. \u5b50\u5bae\u5185\u819c\u7d30\u80de\u8a3a\u306b\u304a\u3051\u308bOsaki Study Group (OSG) \u5f0f\u5224\u5b9a\u306e\u6709\u7528\u6027. \u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u96d1\u8a8c\u00a02021;60:253-259.<\/span><\/span><\/li>\n<\/ol>\n

    \u75c7\u4f8b\u5831\u544a<\/strong><\/span><\/p>\n

      \n
    1. Maekawa K, Tokumitsu T, Noguchi H, Nakamura E, Gi T, Horinouchi S, Yamashita S, Takeshima H, Asada Y, Sato Y. Glioblastoma mimicking metastatic small cell carcinoma: a case report with ultrastructural findings.\u00a0Diagn Cytopathol. 2021;49:E291-E296. <\/span><\/span><\/li>\n
    2. Izumoto S, Oguri N, Koyama S, Matsuura Y, Komatsu H,\u00a0Asada Y, Iwakiri H. Cardiac Strangulation Due to Partial Pericardial Defect Presenting as Acute Myocardial Infarction. JACC Case Rep. 2021;3:1635-1638.<\/span><\/li>\n
    3. Noguchi H, Tokumitsu T, Kuroki E, Minematsu E,\u00a0Asada Y, Kuroda S, Ochiai S, Kikuchi M, Fujimoto S, Onishi J, Kawagoe Y, Sameshima H, Katsuragi S, Sato Y. Detection of Treponema pallidum by immunocytochemistry of cervical smear: A case report. Diagn Cytopathol. 2021;49:E443-E446.<\/span><\/li>\n
    4. Kuroiwa Y, Kusumoto K, Shimata K, Yamashita A, Hibi T, Asada Y, Imamura T. MRI diffusion-weighted imaging detects a fresh portal vein thrombus as a high intensity lesion in a patient with a liver transplant: A case report. Acta Radiologica Open. 2021;10 (12):1-4.<\/span><\/li>\n
    5. Ono Y, Okumura R, Hatanaka KC, SatoY, Ota H, Fukushi Y, Wada S, Yamada H. Case Report The first case of congenital syphilis diagnosed by 16S ribosome-RNA gene sequence analysis JIC. doi: 10.1016\/j.jiac.2021.10.016. Online ahead of print.<\/span><\/li>\n
    6. Setoguchi K, Yanagi S, Gi T, Tsubouchi H, Uto K, Shigekusa T, Matsumoto N, Sato Y, Nakazato M. Transition from distinct types of KRAS mutation-harboring multifocal lung adenocarcinoma to rhabdoid tumor: A longitudinal follow-up. Am J Case Rep 2021 Aug 25;22:e932452. doi: 10.12659\/AJCR.932452.<\/span><\/li>\n
    7. Hamahiro T, Maeda R, Ayabe T, Sato Y, Tomita M. Primary mucinous adenocarcinoma of the thymus: a case report. Respiratory medicine case reports. 2021; 34: 101497.<\/span><\/li>\n
    8. Yamamoto K, Maki Y, Sato Y, Tanaka; H, Fukushima T, Ushijima J, Furukawa S, Sameshima H, Kataoka H. Multiple cardiac rhabdomyomas not associated with tuberous sclerosis in one of dizygotic twins: a clinical\/pathological autopsy case report. Journal of Medical Case Reports. 2021; 15:334.<\/span><\/li>\n
    9. Yamada N, Kodama Y, Goto T, Yamashita R, Doi K, Kaneko M, Sato Y, Sameshima H. A very low birth weight infant with severe red blood cell polyagglutination: A case report. Journal of Neonatal Biology. 2021, 9:1-3.<\/span><\/li>\n
    10. Tsuruda T, Higashi Y, Gi T, Nakao S. Pericardial effusion in the course of Fabry disease cardiomyopathy: a case report. Eur Heart J Case Rep. 2021;5(10):ytab407.<\/span><\/li>\n
    11. Ogawa S, Kawakami H, Suzuki S, Kuroki D, Uchiyama N, Hatada H, Gi T, Sato Y. Metachronous esophageal ulcers after immune-mediated colitis due to immune checkpoint inhibitor therapy: A case report and literature review. Intern Med. 2021;60(17):2783-2791.<\/span><\/li>\n
    12. Setoguchi K, Yanagi S, Gi T, Tsubouchi H, Uto K, Shigekusa T, Matsumoto N, Sato Y, Nakazato M. Transition from distinct types of KRAS mutation-harboring multifocal lung adenocarcinoma to rhabdoid tumor: A longitudinal follow-up. Am J Case Rep. 2021;22:e932452.<\/span><\/li>\n
    13. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u963f\u842c\u7d2b\u3001\u9b4f\u5cfb\u6d38\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5927\u897f\u6df3\u4ec1\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u9bab\u5cf6\u6d69\u3001\u53e4\u7530\u8ce2. Seromucinous carcinoma\u3068\u306e\u9451\u5225\u304c\u56f0\u96e3\u3067\u3042\u3063\u305f\u4f4e\u7570\u578b\u5ea6\u6f3f\u6db2\u6027\u5375\u5de3\u764c\u306e1\u4f8b.\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c 2021; 11(1):23-26.<\/span><\/li>\n
    14. \u6c5f\u85e4\u535a\u6587, \u6301\u7530\u8015\u4ecb, \u9ed2\u6728\u8129\u77e2, \u4f50\u85e4\u52c7\u4e00\u90ce, \u5929\u91ce\u6b63\u5b8f. Primary cutaneous adenoid cystic carcinoma\u306e1\u4f8b. Skin Cancer 2021;36: 76-80.<\/span><\/li>\n
    15. \u52a0\u85e4\u6587\u7ae0, \u5dfb\u5e61\u8070, \u4f50\u85e4\u52c7\u4e00\u90ce, \u934b\u5cf6\u4e00\u6a39, \u5ca9\u5d0e\u662d\u61b2. 17\u5e74\u524d\u306e\u5b50\u5bae\u5e73\u6ed1\u7b4b\u816b\u760d\u6240\u898b\u304b\u3089\u8ee2\u79fb\u6027\u80ba\u5e73\u6ed1\u7b4b\u8089\u816b\u3068\u8a3a\u65ad\u3057\u305f1\u4f8b. \u65e5\u672c\u547c\u5438\u5668\u5916\u79d1\u5b66\u4f1a\u96d1\u8a8c 2021;35(4):332-336<\/span><\/li>\n
    16. \u7551\u7530\u7d18\u5fd7, \u6cb3\u4e0a\u6d0b, \u5185\u5c71\u5c1a\u7f8e, \u5c0f\u5ddd\u5b97\u4e00\u90ce, \u4e45\u4fdd\u7530\u826f\u653f, \u5742\u54f2\u81e3, \u8d64\u6728\u771f\u7531\u7f8e, \u4f50\u85e4\u52c7\u4e00\u90ce. \u526f\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u95a2\u9023\u86cb\u767d\u7523\u751f\u81b5\u817a\u6241\u5e73\u4e0a\u76ae\u764c\u306e1\u4f8b. \u65e5\u672c\u6d88\u5316\u5668\u75c5\u5b66\u4f1a\u96d1\u8a8c 2021; 11(5): 480-489.<\/span><\/li>\n
    17. \u51a8\u68ee\u99a8\u4e88, \u5927\u897f\u6df3\u4ec1, \u5927\u6fa4\u7dbe\u5b50, \u5713\u5d0e\u590f\u7f8e, \u5409\u672c \u671b, \u798f\u5cf6\u548c\u5b50, \u5ddd\u8d8a\u9756\u4e4b, \u4e2d\u6751\u6804\u4f5c, \u4e2d\u6751\u90fd\u82f1, \u9b4f \u5cfb\u6d38, \u4f50\u85e4\u52c7\u4e00\u90ce, \u9bab\u5cf6 \u6d69. \u8179\u90e8\u5927\u52d5\u8108\u5468\u56f2\u30ea\u30f3\u30d1\u7bc0\u306b\u518d\u767a\u3057\u305f\u5b50\u5bae\u9838\u764c\u304c\u4e0b\u5927\u9759\u8108\u306b\u764c\u585e\u6813\u3092\u5f62\u6210\u3057\u305f1\u4f8b. \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c. 2021;45(1):39-43.<\/span><\/li>\n<\/ol>\n

      \u7dcf\u8aac<\/strong><\/span><\/p>\n

        \n
      1. Sato Y. Inflammatory lesions in placental pathology. J Obstet Gynaecol Res. 2021 Nov 2. doi: 10.1111\/jog.14932. Online ahead of print.<\/span><\/li>\n
      2. Matsuura H, Watanabe N, Shibata Y,\u00a0Asada Y. Combination of echocardiography and emergency endomyocardial biopsy for suspected myocarditis in the cardiovascular emergency medical care. J Echocardiogr. 2021;19(2):86-94.<\/span><\/li>\n
      3. \u5c71\u4e0b\u3000\u7be4\u3001\u897f\u5e73\u8ce2\u4f5c\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u51a0\u52d5\u8108\u8840\u6813\u306e\u75c5\u7406. \u75c5\u7406\u3068\u81e8.2021;39:1099-1105.<\/span><\/li>\n
      4. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u30a6\u30b5\u30ae\uff1a\u30d2\u30c8\u306e\u52d5\u8108\u786c\u5316\u3092\u30a6\u30b5\u30ae\u3067\u518d\u73fe. \u533b\u5b66\u306e\u3042\u3086\u307f. 2021;279 (2):169-175.<\/span><\/li>\n
      5. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u8133\u6897\u585e\u306e\u8840\u7ba1\u30fb\u8840\u6813\u75c5\u7406\u3068\u8840\u6813\u306e\u5f62\u6210\u6a5f\u5e8f. BRAIN and NERVE. 2021;73:965-974.<\/span><\/li>\n
      6. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u75c7\u306b\u304a\u3051\u308b\u8840\u6813\u5f62\u6210\u6a5f\u5e8f\u306f\u3069\u3053\u307e\u3067\u308f\u304b\u3063\u305f\u306e\u304b\uff1fHeart View. 2021;25:32-38.<\/span><\/li>\n
      7. \u9b4f\u3000\u5cfb\u6d38\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u8840\u6813\u6027\u75be\u60a3\u306e\u75c5\u7406. 2021;279(11):1084-1089.<\/span><\/li>\n
      8. \u9b4f\u3000\u5cfb\u6d38. \u4ee4\u548c2\u5e74\u5ea6\u65e5\u672c\u75c5\u7406\u5b66\u4f1a 100\u5468\u5e74\u8a18\u5ff5\u75c5\u7406\u5b66\u7814\u7a76\u65b0\u4eba\u8cde \u53d7\u8cde\u4f53\u9a13\u8a18. \u75c5\u7406\u3068\u81e8\u5e8a. 2021;39(11): 1156-1158.<\/span><\/li>\n
      9. \u897f\u7530\u5353\u5f18\u3001\u4f0a\u4e95\u7f8e\u5948\u4ee3\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5c71\u53e3\u660c\u654f\u3001\u4e03\u5cf6\u7be4\u5fd7\u3001\u7d30\u5ddd\u6b69. \u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u306e\u8a72\u5f53\u3068\u5f53\u9662\u306b\u304a\u3051\u308b\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u4f53\u5236\u3065\u304f\u308a. \u5bae\u5d0e\u533b\u4f1a\u8a8c 2021; 45: 122-129.<\/span><\/li>\n<\/ol>\n

        \u66f8\u7c4d<\/strong><\/span><\/p>\n

          \n
        1. \u5c71\u4e0b\u3000\u7be4\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u6d45\u7530\u7950\u58eb\u90ce. <\/span>\u30a6\u30b5\u30ae\u53cd\u5fa9\u50b7\u5bb3\u8840\u6813\u30e2\u30c7\u30eb. <\/span>\u5800\u5185\u4e45\u5fb3 (<\/span>\u7de8). <\/span>\u30e2\u30c7\u30eb\u52d5\u7269\u306e\u4f5c\u88fd\u3068\u5229\u7528. <\/span>\u5faa\u74b0\u5668\u75be\u60a3. <\/span>\u30a8\u30eb\u30fb\u30a2\u30a4\u30fb\u30b7\u30fc. 2021;<\/span>\u4e0a\u5dfb449-453.<\/span><\/span><\/li>\n
        2. \u5c71\u4e0b\u3000\u7be4\u3001\u5927\u6817\u4f38\u884c\u3001\u6d45\u7530\u7950\u58eb\u90ce. <\/span>\u6df1\u90e8\u9759\u8108\u8840\u6813\u30e2\u30c7\u30eb. <\/span>\u5800\u5185\u4e45\u5fb3 (<\/span>\u7de8). <\/span>\u30e2\u30c7\u30eb\u52d5\u7269\u306e\u4f5c\u88fd\u3068\u5229\u7528. <\/span>\u5faa\u74b0\u5668\u75be\u60a3. <\/span>\u30a8\u30eb\u30fb\u30a2\u30a4\u30fb\u30b7\u30fc. 2021;<\/span>\u4e0a\u5dfb454-459.<\/span><\/span><\/li>\n<\/ol>\n

          \u5b66\u4f1a\u767a\u8868<\/strong><\/span><\/p>\n

            \n
          1. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u9b4f\u5cfb\u6d38\u3001\u963f\u842c\u7d2b\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u798f\u5cf6\u525b\u3001\u90fd\u7bc9\u8c4a\u5fb3. \u80ba\u306b\u8ee2\u79fb\u3092\u304d\u305f\u3057\u305f\u524d\u7acb\u817a\u9593\u8cea\u816b\u760d\u306e\u4e00\u4f8b. \u7b2c110\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a. \u6771\u4eac\uff084\/22-24, 2021\uff09<\/span><\/li>\n
          2. \u6771\u771f\u7406\u6075\u3001\u5927\u897f\u6df3\u4ec1\u3001\u90fd\u7bc9\u5eb7\u6075\u3001\u6cb3\u91ce\u731b\u55e3\u3001\u5713\ufa11\u590f\u7f8e\u3001\u85e4\ufa11\u78a7\u3001\u798f\u5cf6\u548c\u5b50\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u9bab\u5cf6\u6d69\u3001\u5927\u6817\u4f38\u884c\u3001\u4f50\u85e4\u52c7\u4e00\u90ce.<\/sup> \u5b50\u5bae\u5185\u819c\u764c\u3068\u5b50\u5bae\u5185\u819c\u9593\u8cea\u8089\u816b\u306e\u91cd\u8907\u764c\u306e\u4e00\u4f8b. \u7b2c73\u56de\u65e5\u672c\u7523\u79d1\u5a66\u4eba\u79d1\u5b66\u4f1a. \u65b0\u6f5f\u5e02\uff084\/22-25, 2021\uff09<\/span><\/li>\n
          3. \u9b4f \u5cfb\u6d38\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5c71\u4e0b \u7be4\u3001\u963f\u842c \u7d2b\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u5927\u6817\u4f38\u884c\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u5375\u5de3\u764c\u306b\u304a\u3051\u308b\u7d44\u7e54\u56e0\u5b50\u767a\u73fe\u304a\u3088\u3073\u816b\u760d\u6d78\u6f64\u30ea\u30f3\u30d1\u7403\u3068\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u3068\u306e\u95a2\u9023. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/28-6\/1, 2021\uff09<\/span><\/li>\n
          4. \u897f\u6751\u6b63\u61b2\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u677e\u6d66\u7950\u4e4b\u4ecb\u3001\u5965\u6d25\u6f64\u4e00\u3001\u6df1\u5800\u611b\u5b50\u3001\u5e73\u7530\u3000\u525b\u4e4b\u3001\u897f\u6fa4\u53cb\u5b8f\u3001\u77f3\u4e95\u5ee3\u4eba\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u4e2d\u6751\u90fd\u82f1\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u6d45\u7530\u7950\u58eb\u90ce.\u3000\u52d5\u8108\u786c\u5316\u6027\u5927\u52d5\u8108\u7624\u306b\u304a\u3051\u308b\u30ad\u30cc\u30ec\u30cb\u30f3\u4ee3\u8b1d\u9175\u7d20\u306e\u767a\u73fe\u3068\u5c40\u5728. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/28-6\/1, 2021\uff09<\/span><\/li>\n
          5. \u5c0f\u5c71\u5f70\u5e73\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u677e\u6d66\u7950\u4e4b\u4ecb\u3001\u658e\u85e4\u7950\u4ecb\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u5317\u6751\u548c\u96c4\u3001\u7d30\u80de\u5185\u30b0\u30eb\u30bf\u30df\u30f3\u6fc3\u5ea6\u306f\u8840\u7ba1\u5e73\u6ed1\u7b4b\u7d30\u80de\u306e\u8840\u6813\u6027\u3092\u898f\u5b9a\u3059\u308b. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/27-6\/1, 2021\uff09<\/span><\/li>\n
          6. \u5927\u6817\u4f38\u884c\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u795e\u5c71\u3000\u7965\u3001\u5927\u5ddd\u661f\u7f8e\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u5bb6\u514e\u9759\u8108\u8840\u6813\u30e2\u30c7\u30eb\u306b\u3088\u308b\u7d4c\u53e3\u6d3b\u6027\u5316\u51dd\u56faXI\u56e0\u5b50\u963b\u5bb3\u85ac(ONO-1600586)\u306e\u6297\u8840\u6813\u4f5c\u7528\u3068\u6b62\u8840\u3078\u306e\u5f71\u97ff. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/27-6\/1, 2021\uff09<\/span><\/li>\n
          7. \u5c71\u4e0b\u3000\u7be4\u3001\u5800\u5185\u3000\u65e9\u7d00\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u7d44\u7e54\u56e0\u5b50\u5857\u5e03\u30d7\u30ec\u30fc\u30c8\u4e0a\u306b\u304a\u3051\u308b\u8840\u5c0f\u677f\u7c98\u7740\u30fb\u51dd\u96c6\u306b\u304a\u3051\u308b\u30d5\u30a3\u30d6\u30ea\u30f3\u3068\u30d5\u30a9\u30f3\u30a6\u30a3\u30eb\u30d6\u30e9\u30f3\u30c9\u56e0\u5b50\u306e\u95a2\u4e0e. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/28-6\/1, 2021\uff09<\/span><\/li>\n
          8. \u4e2d\u6751\u6075\u7406\u5b50\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u897f\u6771\u6d0b\u4e00\u3001\u83f0\u539f\u7fa9\u5f18\u3001\u6d45\u7530\u7950\u58eb\u90ce . \u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u306b\u5bcc\u3080\u52d5\u8108\u786c\u5316\u5de3\u306b\u304a\u3051\u308b\u4ee3\u8b1d\u6307\u6a19\u306e\u540c\u5b9a. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/28-6\/1, 2021\uff09<\/span><\/li>\n
          9. \u9ed2\u5ca9\u9756\u6df3\uff0c\u6960\u5143\u5bff\u5178\uff0c\u5d8b\u7530\u572d\u592a\uff0c\u5c71\u4e0b\u3000\u7be4\uff0c\u571f\u80a5\u7701\u543e\uff0c\u7530\u4e2d\u3000\u9686, \u6728\u539f\u3000\u5eb7\uff0c\u65e5\u6bd4\u6cf0\u9020, \u6d45\u7530\u7950\u58eb\u90ce\uff0c\u4eca\u6751\u3000\u5353\u90ce\uff0e\u751f\u4f53\u809d\u79fb\u690d\u5f8c\u306e\u80c6\u7ba1\u708e\u306b\u5408\u4f75\u3057\u305f\u9580\u8108\u8840\u6813\u75c7\u306e\uff11\u4f8b\uff1aMRI\u62e1\u6563\u5f37\u8abf\u753b\u50cf\u306b\u3088\u308b\u691c\u51fa\u3068\u8cea\u7684\u8a55\u4fa1. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/28-6\/1, 2021\uff09<\/span><\/li>\n
          10. \u524d\u5ddd\u548c\u4e5f\u3001\u8fbb\u3000\u539a\u81f3\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u9808\u582f\u3000\u7dbe\u3001\u52a0\u85e4\u5343\u6075\u6b21\u3001Minghui Tang\u3001\u897f\u5e73\u8ce2\u4f5c\u3001\u67f4\u7530\u525b\u5fb3\u3001\u8d8a\u672c\u77e5\u5927\u3001Ming-Rong Zhang\u3001\u897f\u4e95\u9f8d\u4e00\u3001\u5409\u6c38\u6075\u4e00\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce. Translocator protein\u3092\u6a19\u7684\u3068\u3057\u305f\u30cf\u30a4\u30ea\u30b9\u30af\u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u691c\u51fa. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/28-6\/1, 2021\uff09<\/span><\/li>\n
          11. \u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u68ee\u7530\u52dd\u4ee3\u3001\u5cf0\u677e\u6620\u5b50\u3001\u767d\u6ff1\u5e78\u751f\u3001\u9ed2\u6728\u6804\u8f1d\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u4f50\u85e4\u52c7\u4e00\u90ce. \u817a\u764c\u3068\u8aa4\u5224\u5b9a\u3057\u305f\u80ba\u985e\u4e0a\u76ae\u6027\u8840\u7ba1\u5185\u813e\u816b\u306e1\u75c7\u4f8b. \u7b2c62\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a.\u5343\u8449\u5e02\uff086\/4-6, 2021\uff09<\/span><\/li>\n
          12. \u5fb3\u6e80\u8cb4\u5b50\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5cf0\u677e\u6620\u5b50\u3001\u68ee\u7530\u52dd\u4ee3\u3001\u767d\u6ff1\u5e78\u751f\u3001\u9ed2\u6728\u6804\u8f1d\u3001\u795e\u7530\u4fee\u53f8\u3001\u963f\u842c\u7d2b\u3001\u7530\u4e2d\u5f18\u4e4b\u3001\u4f50\u85e4\u52c7\u4e00\u90ce. \u5f53\u9662\u306b\u304a\u3051\u308b\u81b5EUS\uff0dFNA\u306e\u7d30\u80de\u8a3a\u304a\u3088\u3073\u7d44\u7e54\u8a3a\u65ad\u7d50\u679c\u3068\u624b\u8853\u7d44\u7e54\u3067\u306e\u81b5\u83c5\u764c\u8a3a\u65ad\u75c7\u4f8b\u3068\u306e\u6bd4\u8f03\u691c\u8a0e. \u7b2c62\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a.\u5343\u8449\u5e02\uff086\/4-6, 2021\uff09<\/span><\/li>\n
          13. \u767d\u6ff1\u5e78\u751f\u3001\u6e05\u5c71\u548c\u662d\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u68ee\u7530\u52dd\u4ee3\u3001\u5cf0\u677e\u6620\u5b50\u3001\u9ed2\u6728\u6804\u8f1d\uff09\u3001\u6797\u900f\u3001 \u4f50\u85e4\u52c7\u4e00\u90ce. \u5b50\u5bae\u5185\u819c\u7d30\u80de\u8a3a\u306b\u304a\u3051\u308bOSG\u5f0f\u5224\u5b9a\u6cd5\u3068\u5f93\u6765\u5224\u5b9a\u6cd5\u306e\u6bd4\u8f03. \u7b2c62\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a. \u5343\u8449\u5e02\uff086\/4-6, 2021\uff09<\/span><\/li>\n
          14. \u5c71\u6751\u5584\u653f\u3001\u677e\u6d66\u7950\u4e4b\u4ecb\u3001\u77f3\u5ddd\u54f2\u61b2\u3001\u5317\u6751\u548c\u96c4\u3001\u9b4f\u5cfb\u6d38\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u5fc3\u81d3 MRI \u3067\u306e\u75c5\u5909\u306e\u4e0d\u5747\u4e00\u6027\u3092\u5448\u3057\u305f AL \u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306b\u5bfe\u3057\u3066\u4e21\u5fc3\u5ba4\u5fc3\u7b4b\u751f\u691c\u3092\u884c\u3063\u305f\u4e00\u4f8b. \u7b2c42\u56de\u5fc3\u7b4b\u751f\u691c\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5927\u962a\u5e02\uff086\/12, 2021)<\/span><\/li>\n
          15. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6728\u8107\u62d3\u9053\u3001\u7530\u4e2d\u5f18\u4e4b\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u5927\u897f\u6df3\u4ec1\u3001\u6842\u6728\u771f\u53f8. \u6f3f\u6db2\u6027\u764c\u3068\u672a\u5206\u5316\u764c\u306e\u5b50\u5bae\u4f53\u90e8\u6df7\u5408\u764c\u306e1\u4f8b. \u7b2c52\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a. \u76db\u5ca1\u5e02 (7\/31, 2021)<\/span><\/li>\n
          16. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5927\u6817\u4f38\u884c\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u6e21\u9089\u5b5d\u3001\u6cb3\u91ce\u667a\u6a39\u3001\u6a2a\u4e0a\u8056\u8cb4\u3001\u7af9\u5cf6\u79c0\u96c4. \u982d\u84cb\u54bd\u982d\u816b\u518d\u767a\u75c7\u4f8b\u306e1\u4f8b. \u7b2c110\u56de\u65e5\u672c\u795e\u7d4c\u75c5\u7406\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. \u4e45\u7559\u7c73\u5e02 (9\/11, 2021)<\/span><\/li>\n
          17. Koyama S, Yamashita A, Matsuura Y, Saito Y, Maekawa K, Gi T, Kitamura K, Kaikita K, Asada Y. Increased vascular glutamine level is a possible mediator of antithrombotic effect after everolimus-eluting stent implantation. The 19th<\/sup> International Symposium on Atherosclerosis. Kyoto (10\/24-27, 2021)<\/span><\/li>\n
          18. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u76db\u53e3\u6e05\u9999\u3001\u9b4f\u5cfb\u6d38\u3001\u5c71\u4e0b\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u4e00\u904e\u6027\u9aa8\u9ac4\u7570\u5e38\u5897\u6b96\u75c75\u4f8b\u306e\u80ce\u76e4\u6240\u898b. \u7b2c67\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u79cb\u5b63\u7279\u5225\u7dcf\u4f1a. \u5ca1\u5c71\u5e02\uff0811\/4-5, 2021\uff09<\/span><\/li>\n
          19. \u9b4f\u3000\u5cfb\u6d38\u3001\u897f\u91ce\u3000\u5cfb\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u6e21\u9089\u3000\u671b\u3001\u67f4\u7530\u525b\u5fb3\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u51a0\u52d5\u8108\u306b\u591a\u767a\u6027\u30d7\u30e9\u30fc\u30af\u7834\u88c2\u3092\u8a8d\u3081\u305f\u6025\u6027\u5fc3\u7b4b\u6897\u585e\u306e\u4e00\u5256\u691c\u4f8b. \u7b2c67\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a \u79cb\u671f\u7279\u5225\u7dcf\u4f1a. \u5ca1\u5c71\u5e02\uff0811\/4-5, 2021)<\/span><\/li>\n
          20. \u68ee\u7530\u52dd\u4ee3\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u767d\u6ff1\u5e78\u751f\u3001\u5cf0\u677e\u6620\u5b50\u3001\u9ed2\u6728\u6804\u8f1d\u3001\u76db\u53e3\u6df8\u9999\u3001\u7530\u4e2d\u5f18\u4e4b\u3001\u4f50\u85e4\u52c7\u4e00\u90ce.\u81ea\u7136\u5c3f\u7d30\u80de\u8a3a\u3067\u7d4c\u9a13\u3057\u305f\u5c0f\u7d30\u80de\u764c\u306e3\u75c7\u4f8b. \u7b2c60\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927. \u7c73\u5b50\u5e02\uff0811\/20-21, 2021\uff09<\/span><\/li>\n
          21. \u5cf0\u677e\u6620\u5b50\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u767d\u6ff1\u5e78\u751f\u3001\u9ed2\u6728\u6804\u8f1d\u3001\u68ee\u7530\u52dd\u4ee3\u3001\u4f50\u85e4\u52c7\u4e00\u90ce. \u5b50\u5bae\u9838\u90e8LBC\u6a19\u672c\u304b\u3089\u514d\u75ab\u7d30\u80de\u5316\u5b66\u306b\u3088\u308a\u6885\u6bd2\u30c8\u30ec\u30dd\u30cd\u30fc\u30de\u83cc\u4f53\u3092\u691c\u51fa\u3057\u305f\uff11\u4f8b. \u7b2c60\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a. \u7c73\u5b50\u5e02\uff0811\/20-21, 2021\uff09<\/span><\/li>\n
          22. \u5c71\u4e0b\u3000\u7be4\u3001\u5c0f\u5c71\u5f70\u5e73\u3001\u677e\u6d66\u7950\u4e4b\u4ecb\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u6d77\u5317\u5e78\u4e00\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u30b0\u30eb\u30bf\u30df\u30f3\u306f\u8840\u7ba1\u5e73\u6ed1\u7b4b\u7d30\u80de\u306e\u51dd\u56fa\u6d3b\u6027\u306b\u95a2\u4e0e\u3059\u308b. \u7b2c26\u56de\u65e5\u672c\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a. \u5bae\u5d0e (11\/27, 2021\uff09<\/span><\/li>\n
          23. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u76db\u53e3\u6df8\u9999\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5927\u6fa4\u7dbe\u5b50\u3001\u85e4\ufa11\u78a7\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u5927\u897f\u6df3\u4ec1\u3001\u6842\u6728\u3000\u771f\u53f8. \u795e\u7d4c\u5185\u5206\u6ccc\u5206\u5316\u3092\u4f34\u3063\u305f\u5375\u5de3\u985e\u5185\u819c\u764c\u306e1\u4f8b. \u7b2c53\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a. \u6771\u4eac (12\/4, 2021)<\/span><\/li>\n<\/ol>\n

            \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u306a\u3069<\/strong><\/span><\/p>\n

              \n
            1. \u5c71\u4e0b\u3000\u7be4. \u9759\u8108\u8840\u6813\u75c7\u306e\u75c5\u7406\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/28-6\/1, 2021\uff09<\/span><\/li>\n
            2. \u9b4f\u3000\u5cfb\u6d38, \u6d45\u7530\u7950\u58eb\u90ce. Histopathological analysis of thrombotic factor expression in cancer tissue.\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09. \u7b2c43\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff085\/28-6\/1, 2021\uff09<\/span><\/li>\n
            3. \u4f50\u85e4\u52c7\u4e00\u90ce. \u80ce\u76e4\u75c5\u7406\u3068\u8840\u6813\u75c7\uff08\u6559\u80b2\u8b1b\u6f14\uff09\u7b2c57\u56de\u65e5\u672c\u5468\u7523\u671f\u30fb\u65b0\u751f\u5150\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u5bae\u5d0e\u5e02\uff087\/11-13, 2021\uff09<\/span><\/li>\n
            4. Yamashita A. Detection and safety prevention of deep vein thrombosis (Symposium). The 19th<\/sup>International Symposium on Atherosclerosis. Kyoto, Japan (10\/24-27, 2021).<\/span><\/li>\n
            5. \u5c71\u4e0b\u3000\u7be4. \u7834\u88c2\u6027\u51a0\u52d5\u8108\u306e\u75c5\u7406\u3068\u30e2\u30c7\u30eb\u52d5\u7269\u306ePET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09. \u7b2c53\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a. \u4eac\u90fd\uff0810\/23-24, 2021\uff09<\/span><\/li>\n
            6. \u5c71\u4e0b\u3000\u7be4. \u8840\u6813\u75c7\u306e\u767a\u75c7\u306b\u7e4b\u304c\u308b\u8840\u6813\u306e\u767a\u751f\u304a\u3088\u3073\u6210\u9577\u6a5f\u5e8f\u306e\u89e3\u660e\uff08A\u6f14\u8aac\uff09. \u7b2c67\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u79cb\u671f\u7279\u5225\u7dcf\u4f1a. \u5ca1\u5c71\u5e02\uff0811\/4-5, 2021\uff09<\/span><\/li>\n<\/ol>\n

              \u4e5d\u5dde\u6c96\u7e04\u30b9\u30e9\u30a4\u30c9\u30b3\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9<\/strong><\/span><\/p>\n

                \n
              1. \u5927\u6817\u4f38\u884c\uff1a\u809d\u81d3\u816b\u760d\u3000(Intraductal papillary neoplasm of the bile duct).<\/span>
                \n\u7b2c379\u56de\uff082021.1.23.\u5bae\u5d0e\u5927\u5b66\u3001\u5bae\u5d0e\u5e02, web\u958b\u50ac\uff09<\/span><\/li>\n
              2. \u4e0a\u6751\u54f2\uff1a\u5f8c\u982d\u90e8\u76ae\u819a\u816b\u760d(Proliferating\/proliferative trichilemmal tumor\/cyst)\uff0e<\/span>
                \n\u7b2c379\u56de\uff082021.1.23.\u5bae\u5d0e\u5927\u5b66\u3001\u5bae\u5d0e\u5e02, web\u958b\u50ac\uff09<\/span><\/li>\n
              3. \u4e2d\u6751\u6075\u7406\u5b50\uff1a\u76ae\u819a\u816b\u760d(Tufted angioma\/ Kaposiform hemangioendothelioma)\uff0e<\/span>
                \n\u7b2c380\u56de\uff082021.3.6.\u65e5\u672c\u8d64\u5341\u5b57\u793e\u9577\u5d0e\u539f\u7206\u75c5\u9662\u3001\u9577\u5d0e\u5e02, web\u958b\u50ac\uff09<\/span><\/li>\n
              4. \u9b4f\u5cfb\u6d38\uff1a\u53f3\u80ba\u816b\u760d(Pulmonary papillary adenoma)\uff0e<\/span>
                \n\u7b2c381\u56de\uff082021.5.15.\u4e5d\u5dde\u5927\u5b66\u3001\u798f\u5ca1\u5e02, web\u958b\u50ac\uff09<\/span><\/li>\n
              5. \u5927\u6817\u4f38\u884c\uff1a\u53f3\u4e73\u623f\u816b\u760d(Neuroendocrine tumor)\uff0e<\/span>
                \n\u7b2c382\u56de\uff082021.7.17.\u718a\u672c\u5e02\u6c11\u75c5\u9662\u3001\u718a\u672c\u5e02, web\u958b\u50ac\uff09<\/span><\/li>\n
              6. \u9b4f\u5cfb\u6d38\uff1a\u53f3\u4e0b\u817f\u76ae\u819a\/\u89d2\u5316\u6027\u7d05\u6591(Hypertrophic lichen planus)\uff0e<\/span>
                \n\u7b2c383\u56de\uff082021.9.25.\u798f\u5ca1\u5927\u5b66\u3001\u798f\u5ca1\u5e02, web\u958b\u50ac\uff09<\/span><\/li>\n<\/ol>\n

                \u4e5d\u5dde\u75c5\u7406\u96c6\u8ac7\u4f1a<\/strong><\/span><\/p>\n

                  \n
                1. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1aSARS-Cov-2 \u611f\u67d3\u5f8c\u306e\u5256\u691c\u4f8b<\/span>
                  \n\u7b2c94\u56de\uff082021.7.17.\u718a\u672c\u5e02\u6c11\u75c5\u9662\u3001\u718a\u672c\u5e02, web\u958b\u50ac\uff09<\/span><\/li>\n<\/ol>\n

                  \u53d7\u8cde<\/strong><\/span><\/p>\n

                    \n
                  1. \u9b4f\u3000\u5cfb\u6d38\u3000\u65e5\u672c\u75c5\u7406\u5b66\u4f1a100\u5468\u5e74\u8a18\u5ff5\u75c5\u7406\u5b66\u7814\u7a76\u65b0\u4eba\u8cde<\/span><\/li>\n
                  2. \u5c71\u4e0b\u3000\u7be4\u3000\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u79cb\u671f\u7279\u5225\u7dcf\u4f1a\u3000\u5b66\u8853\u7814\u7a76\u8cde\uff08A\u6f14\u8aac\uff09<\/span><\/li>\n
                  3. \u897f\u91ce\u3000\u5cfb\u3000\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a YIA\u6700\u512a\u79c0\u8cde<\/li>\n<\/ol>\n

                    \u7814\u7a76\u52a9\u6210<\/strong><\/span><\/p>\n

                      \n
                    1. \u5c71\u4e0b\u3000\u7be4\u3000\u4e00\u822c\u8ca1\u56e3\u6cd5\u4eba\u3000\u85e4\u4e95\u7bc0\u6717\u8a18\u5ff5\u5927\u962a\u57fa\u790e\u533b\u5b66\u7814\u7a76\u5968\u52b1\u4f1a\u3000\u4ee4\u548c3\u5e74\u5ea6\u7814\u7a76\u52a9\u6210<\/span><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                      \u539f\u8457\u8ad6\u6587 Yamashita A, Nishihira K, Gi T, Maekawa K, Hatakeyama K, Horiuchi S, Wada K, Shibata Y, Asada Y. Patholog … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":96,"featured_media":0,"parent":17,"menu_order":-16,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false},"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/298"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/users\/96"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/comments?post=298"}],"version-history":[{"count":11,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/298\/revisions"}],"predecessor-version":[{"id":661,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/298\/revisions\/661"}],"up":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/17"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/media?parent=298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}